Department of Nursing and Physiotherapy, University of Lleida, Lleida, Spain.
Research group of health care (GRECS), Institut de Recerca Biomèdica de Lleida Fundació Dr Pifarré, Lleida, Spain.
BMJ Open. 2023 May 10;13(5):e070012. doi: 10.1136/bmjopen-2022-070012.
Non-pharmacological approaches have shown promising results in improving symptoms and quality of life of patients with fibromyalgia. However, these approaches may not be easily accessible or feasible for everyone. eHealth interventions may offer a more convenient and cost-effective approach to reach a wider range of patients with fibromyalgia and improve their outcomes. As eHealth tools become more prevalent in clinical practice, it is crucial to understand their effectiveness, limitations and how they can be integrated into standard care to optimise clinical outcomes. This systematic review aims to evaluate the effectiveness of eHealth therapeutic education interventions in managing fibromyalgia.
Randomised controlled trials including eHealth therapeutic education interventions for individuals ≥18 years old with fibromyalgia, published in English or Spanish, will be retrieved by searching the databases PubMed, CINAHL Plus, EMBASE, Scopus, ISI Web of Science, PsycINFO and the Cochrane Central Register of Controlled Trials. Covidence software will be used for the selection of studies and data extraction. The risk of bias and the certainty of evidence will be assessed using the Cochrane Risk of Bias Assessment tool. We plan to perform a meta-analysis contingent on the number of studies retrieved and the interstudy heterogeneity, which will be explored with I statistics.
This protocol and the subsequent systematic review will not collect individual-level data and do not require approval by an ethical committee. We intend to disseminate the study results via peer-reviewed scientific journals and relevant (inter)national conferences.
CRD42022343373.
非药物干预措施已显示出在改善纤维肌痛患者的症状和生活质量方面具有很大的潜力。然而,这些方法可能不是每个人都容易获得或可行的。电子健康干预措施可能为更广泛的纤维肌痛患者提供一种更方便、更具成本效益的方法,并改善他们的结局。随着电子健康工具在临床实践中变得越来越普遍,了解它们的有效性、局限性以及如何将它们整合到标准护理中以优化临床结果至关重要。本系统评价旨在评估电子健康治疗教育干预措施在管理纤维肌痛中的有效性。
将检索包含≥18 岁纤维肌痛患者的电子健康治疗教育干预措施的随机对照试验,发表语言为英语或西班牙语,检索数据库包括 PubMed、CINAHL Plus、EMBASE、Scopus、ISI Web of Science、PsycINFO 和 Cochrane 对照试验中心注册库。Covidence 软件将用于研究选择和数据提取。将使用 Cochrane 偏倚风险评估工具评估偏倚风险和证据的确定性。我们计划根据检索到的研究数量和研究间异质性进行荟萃分析,并使用 I 统计量进行探索。
本方案和随后的系统评价不会收集个体水平的数据,因此不需要伦理委员会的批准。我们打算通过同行评议的科学期刊和相关的(国际)会议传播研究结果。
PROSPERO 注册号:CRD42022343373。